Literature DB >> 16871385

Protruding disordered loop of gC1qR is specifically exposed and related to antiapoptotic property in germ cell lineage.

Sohei Kitazawa1, Atsushi Takenaka, Takeshi Kondo, Akira Mizoguchi, Riko Kitazawa.   

Abstract

We established a monoclonal antibody (MAb), 5G9, with the use of a fixed seminoma tissue from an archival paraffin-embedded specimen, as an immunogen. Without antigen retrieval, positive 5G9-immunohistochemical staining was confined mostly to primordial germ cells, spermatogonia and various germ cell tumors. 5G9 recognized a mitochondrial 32-kD protein with an isoelectric point of pH 4.2, identified as a multifunctional ubiquitous protein, receptor for globular head of C1q (gC1qR), whose epitope was mapped in a disordered loop connecting the beta3 and the beta4 strands. Reflecting the ubiquitous distribution of gC1qR, with antigen retrieval, 5G9 was found reactive to a wide range of normal and tumor tissues. Since several co-precipitated and phosphorylated bands were observed in various human cell lines but not in germ cell tumor cell lines by in vitro phosphorylation assay, we speculate that the epitope of gC1qR is specifically unmasked in the germ cell lineage. By reducing gC1qR by siRNA, a significant increase was observed in the number of apoptotic cells in ITO-II and TCam-2 cell lines, but to a lesser extent in the Colo201 colon cancer cell line, showing an antiapoptotic property of gC1qR in the germ cells. Since protein-protein interaction is partially preserved by fixation, archival paraffin-embedded specimens can be a valuable source of immunogens for generating monoclonal antibodies (MAbs) that recognize tissue-specific protein conformation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16871385     DOI: 10.1007/s00418-006-0225-y

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  50 in total

1.  Identification of methylated cytosine from archival formalin-fixed paraffin-embedded specimens.

Authors:  S Kitazawa; R Kitazawa; S Maeda
Journal:  Lab Invest       Date:  2000-02       Impact factor: 5.662

2.  The receptor for the globular "heads" of C1q, gC1q-R, binds to fibrinogen/fibrin and impairs its polymerization.

Authors:  P D Lu; D K Galanakis; B Ghebrehiwet; E I Peerschke
Journal:  Clin Immunol       Date:  1999-03       Impact factor: 3.969

3.  Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2-p12.1.

Authors:  S Rodriguez; O Jafer; H Goker; B M Summersgill; G Zafarana; A J M Gillis; R J H L M van Gurp; J W Oosterhuis; Y-J Lu; R Huddart; C S Cooper; J Clark; L H J Looijenga; J M Shipley
Journal:  Oncogene       Date:  2003-03-27       Impact factor: 9.867

4.  Specific interactions between gC1qR and alpha1-adrenoceptor subtypes.

Authors:  Andre S Pupo; Kenneth P Minneman
Journal:  J Recept Signal Transduct Res       Date:  2003       Impact factor: 2.092

Review 5.  Structure and function of gC1q-R: a multiligand binding cellular protein.

Authors:  B Ghebrehiwet; E I Peerschke
Journal:  Immunobiology       Date:  1998-08       Impact factor: 3.144

6.  Intracellular localization of the human receptor for the globular domains of C1q.

Authors:  R H van den Berg; F Prins; M C Faber-Krol; N J Lynch; W Schwaeble; L A van Es; M R Daha
Journal:  J Immunol       Date:  1997-04-15       Impact factor: 5.422

7.  Molecular cloning of human fibroblast hyaluronic acid-binding protein confirms its identity with P-32, a protein co-purified with splicing factor SF2. Hyaluronic acid-binding protein as P-32 protein, co-purified with splicing factor SF2.

Authors:  T B Deb; K Datta
Journal:  J Biol Chem       Date:  1996-01-26       Impact factor: 5.157

8.  Defining minimum genomic regions of imbalance involved in testicular germ cell tumors of adolescents and adults through genome wide microarray analysis of cDNA clones.

Authors:  Alan McIntyre; Brenda Summersgill; Osman Jafer; Sandrine Rodriguez; Gaetano Zafarana; J Wolter Oosterhuis; Ad Jm Gillis; Leendert Looijenga; Colin Cooper; Robert Huddart; Jeremy Clark; Janet Shipley
Journal:  Oncogene       Date:  2004-12-02       Impact factor: 9.867

9.  [Establishment and characterization of a new human testicular germ cell tumor cell line (TCam-2)].

Authors:  Y Mizuno; A Gotoh; S Kamidono; S Kitazawa
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  1993-07

10.  Pediatric testicular tumors: contemporary incidence and efficacy of testicular preserving surgery.

Authors:  Peter D Metcalfe; H Farivar-Mohseni; Walid Farhat; Gordon McLorie; Antoine Khoury; Darius J Bägli
Journal:  J Urol       Date:  2003-12       Impact factor: 7.450

View more
  4 in total

Review 1.  The histochemistry and cell biology vade mecum: a review of 2005-2006.

Authors:  Douglas J Taatjes; Christian Zuber; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2006-11-24       Impact factor: 4.304

2.  Elevated expression of hyaluronic acid binding protein 1 (HABP1)/P32/C1QBP is a novel indicator for lymph node and peritoneal metastasis of epithelial ovarian cancer patients.

Authors:  Hongyang Yu; Qian Liu; Tao Xin; Lina Xing; Guanglu Dong; Qiuying Jiang; Yanju Lv; Xiaowei Song; Chong Teng; Dayong Huang; Yanju Li; Weixi Shen; Chong Teng; Yinghua Jin; Fubin Zhang
Journal:  Tumour Biol       Date:  2013-08-09

Review 3.  Cancer stem cells as targets for cancer therapy: selected cancers as examples.

Authors:  Sabine Hombach-Klonisch; Ted Paranjothy; Emilia Wiechec; Paola Pocar; Tarek Mustafa; Anja Seifert; Christian Zahl; Klaus Luis Gerlach; Katharina Biermann; Klaus Steger; Cuong Hoang-Vu; Klaus Schulze-Osthoff; Marek Los
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-05-30       Impact factor: 4.291

4.  Novel sequential therapy with metformin enhances the effects of cisplatin in testicular germ cell tumours via YAP1 signalling.

Authors:  Kancheng He; Zitaiyu Li; Kun Ye; Yihong Zhou; Minbo Yan; Hao Qi; Huating Hu; Yingbo Dai; Yuxin Tang
Journal:  Cancer Cell Int       Date:  2022-03-09       Impact factor: 5.722

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.